{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:46:36Z","timestamp":1793501196341,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":209,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.jfma.2023.07.018","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T08:11:03Z","timestamp":1691741463000},"page":"S92-S100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis"],"prefix":"10.1016","volume":"122","author":[{"given":"Chen-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jou-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Fan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Wei","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shau-Huai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-6160","authenticated-orcid":false,"given":"Jawl-Shan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstr\u00f6m","year":"2020","journal-title":"Arch Osteoporos"},{"issue":"9","key":"10.1016\/j.jfma.2023.07.018_bib2","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"GBD 2019 Fracture Collaborators. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"11","key":"10.1016\/j.jfma.2023.07.018_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00019053-200725110-00003","article-title":"The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature","volume":"25","author":"Fleurence","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"29","key":"10.1016\/j.jfma.2023.07.018_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6290","article-title":"Treatment of established osteoporosis: a systematic review and cost-utility analysis","volume":"6","author":"Kanis","year":"2002","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.jfma.2023.07.018_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jfma.2016.03.006","article-title":"Establishing and evaluating FRAX(\u00ae) probability thresholds in Taiwan","volume":"116","author":"Chan","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11657-021-01020-6","article-title":"Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan","volume":"16","author":"Johnson","year":"2021","journal-title":"Arch Osteoporos"},{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11657-017-0385-5","article-title":"Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013","volume":"12","author":"Wang","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"2","key":"10.1016\/j.jfma.2023.07.018_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00198-015-3238-3","article-title":"The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan","volume":"27","author":"Chang","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jfma.2023.07.018_bib9","series-title":"International population reports, P95\/22-1, Asia aging: demographic, economic, and health transitions","author":"He","year":"2022"},{"key":"10.1016\/j.jfma.2023.07.018_bib10","series-title":"Ageing in Asia and the pacific: overview","author":"ESCAP, UN","year":"2017"},{"issue":"5\u20136","key":"10.1016\/j.jfma.2023.07.018_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0898264318824180","article-title":"Comparison of population aging in Europe and Asia using a time-consistent and comparative aging measure","volume":"32","author":"Balachandran","year":"2020","journal-title":"J Aging Health"},{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib12","first-page":"1","article-title":"Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey","volume":"4","author":"Liu","year":"2006","journal-title":"J Health Manag"},{"issue":"2\u20133","key":"10.1016\/j.jfma.2023.07.018_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.healthpol.2011.08.007","article-title":"Urbanization and the utilization of outpatient services under national health insurance in Taiwan","volume":"103","author":"Lin","year":"2011","journal-title":"Health Pol"},{"issue":"6","key":"10.1016\/j.jfma.2023.07.018_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/joim.13354","article-title":"Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: a population-based cohort study","volume":"290","author":"Fu","year":"2021","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.jfma.2023.07.018_bib15","first-page":"470","article-title":"Impact of the requirement of bone mineral density evidence on utilization of anti-osteoporosis medications, clinical outcome and medical expenditures of patient with hip fracture in Taiwan","volume":"11","author":"Wang","year":"2022","journal-title":"Int J Health Policy Manag"},{"issue":"6","key":"10.1016\/j.jfma.2023.07.018_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bjan.2019.09.004","article-title":"[Perioperative complications and mortality in elderly patients following surgery for femoral fracture: prospective observational study]","volume":"69","author":"Barbosa","year":"2019","journal-title":"Braz J Anesthesiol"},{"issue":"5","key":"10.1016\/j.jfma.2023.07.018_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological Therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","article-title":"Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis","volume":"24","author":"Freemantle","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jfma.2023.07.018_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15598608.2012.695571","article-title":"Median-based incremental cost-effectiveness ratio (ICER)","volume":"6","author":"Bang","year":"2012","journal-title":"J Stat Theory Pract"},{"issue":"12","key":"10.1016\/j.jfma.2023.07.018_bib20","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jfma.2023.07.018_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00198-003-1533-x","article-title":"Changes in quality of life among elderly patients with hip fracture in Taiwan","volume":"15","author":"Shyu","year":"2004","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jfma.2023.07.018_bib22","first-page":"12","article-title":"Prognostic factors for mortality, activity of daily living, and quality of life in Taiwanese older patients within 1 Year following hip fracture surgery","author":"Chiang","year":"2022","journal-title":"J Pers Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:50:20Z","timestamp":1760539820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":22,"alternative-id":["S0929664623002929"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.07.018","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}